Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wang

Showing results (591-600 of 603) with videos related to

Pageof 61
Sort By:
Molecular Pharmaceutics|September 30, 2024
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary ReportTycho Heimbach, Flora Musuamba Tshinanu, Kimberly Raines, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2025
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract CancersXin Wang, Jaime Ivan Haro-Silerio, Felix Emile Gastonguay Beaudry, et al.
Molecular Cancer|December 9, 2023
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human studyYunlin Zhang, Ruchi P Patel, Ki Hyun Kim, et al.
Blood Cancer Discovery|May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell LymphomaNeeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
The New England Journal of Medicine|February 22, 2023
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia BSteven W Pipe, Frank W G Leebeek, Michael Recht, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Lancet (London, England)|March 7, 2021
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 studyAnthony R Mato, Nirav N Shah, Wojciech Jurczak, et al.
Canadian Journal of Kidney Health and Disease|January 13, 2022
Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical TrialAmit X Garg, Meaghan Cuerden, Hector Aguado, et al.
Science Immunology|July 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P Patel, Guido Ghilardi, Yunlin Zhang, et al.
Blood Advances|October 24, 2023
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphomaJames N Gerson, Elizabeth Handorf, Diego Villa, et al.
Pageof 61

Showing results (591-600 of 603) with videos related to

Sort By:
Pageof 61
Molecular Pharmaceutics|September 30, 2024
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary ReportTycho Heimbach, Flora Musuamba Tshinanu, Kimberly Raines, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2025
Clinicogenomic Characterization of Primary Sclerosing Cholangitis-Associated Biliary Tract CancersXin Wang, Jaime Ivan Haro-Silerio, Felix Emile Gastonguay Beaudry, et al.
Molecular Cancer|December 9, 2023
Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human studyYunlin Zhang, Ruchi P Patel, Ki Hyun Kim, et al.
Blood Cancer Discovery|May 9, 2022
Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell LymphomaNeeraj Y Saini, David M Swoboda, Uri Greenbaum, et al.
The New England Journal of Medicine|February 22, 2023
Gene Therapy with Etranacogene Dezaparvovec for Hemophilia BSteven W Pipe, Frank W G Leebeek, Michael Recht, et al.
Blood|October 23, 2024
Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapyRishika Prasad, Abdur Rehman, Lubna Rehman, et al.
Lancet (London, England)|March 7, 2021
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 studyAnthony R Mato, Nirav N Shah, Wojciech Jurczak, et al.
Canadian Journal of Kidney Health and Disease|January 13, 2022
Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical TrialAmit X Garg, Meaghan Cuerden, Hector Aguado, et al.
Science Immunology|July 19, 2024
CD5 deletion enhances the antitumor activity of adoptive T cell therapiesRuchi P Patel, Guido Ghilardi, Yunlin Zhang, et al.
Blood Advances|October 24, 2023
Outcomes of patients with blastoid and pleomorphic variant mantle cell lymphomaJames N Gerson, Elizabeth Handorf, Diego Villa, et al.
Pageof 61